Radhika Krishnan Net Worth

The estimated Net Worth of Radhika Krishnan is at least $118 Thousand dollars as of 31 March 2024. Ms. Krishnan owns over 2,858 units of 3D Systems stock worth over $21,681 and over the last 5 years she sold DDD stock worth over $96,299. In addition, she makes $0 as Executive Vice President - Software and Healthcare at 3D Systems.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Ms. Krishnan DDD stock SEC Form 4 insiders trading

Radhika has made over 4 trades of the 3D Systems stock since 2020, according to the Form 4 filled with the SEC. Most recently she exercised 2,858 units of DDD stock worth $6,259 on 31 March 2024.

The largest trade she's ever made was exercising 7,042 units of 3D Systems stock on 9 December 2021 worth over $15,422. On average, Radhika trades about 2,867 units every 213 days since 2020. As of 31 March 2024 she still owns at least 9,900 units of 3D Systems stock.

You can see the complete history of Ms. Krishnan stock trades at the bottom of the page.

Radhika Krishnan biography

Radhika Krishnan serves as Executive Vice President - Software and Healthcare of the Company. Ms. Krishnan has served as Executive Vice President, Software and Healthcare since January 2020 after joining the Company in November 2018 as Senior Vice President, Software. From February 2016 to March 2018, she served as Vice President/General Manager, Cloud Infrastructure for Lenovo Datacenter Group, a division of Lenovo Group. Prior to that, Ms. Krishnan served as Vice President, Products, Solutions and Alliances of Nimble Storage from July 2011 until January 2016. Ms. Krishnan has served on the board of directors of Laxmi Therapeutic Devices, a privately held medical development company, since July 2018.

How old is Radhika Krishnan?

Radhika Krishnan is 49, she's been the Executive Vice President - Software and Healthcare of 3D Systems since 2020. There are 18 older and 7 younger executives at 3D Systems. The oldest executive at 3D Systems Corp. is Dr. Charles W. Hull, 81, who is the Co-Founder, Exec. VP, CTO of Regenerative Medicine & Director.

What's Radhika Krishnan's mailing address?

Radhika's mailing address filed with the SEC is 333, Three D Systems Circle, Rock Hill, York County, South Carolina, 29730, United States.

Insiders trading at 3D Systems

Over the last 14 years, insiders at 3D Systems have traded over $140,581,615 worth of 3D Systems stock and bought 532,605 units worth $6,075,291 . The most active insiders traders include G Walter Ii Loewenbaum, Abraham N Reichental, and Vyomesh Joshi. On average, 3D Systems executives and independent directors trade stock every 25 days with the average trade being worth of $60,930. The most recent stock trade was executed by Thomas W Erickson on 28 November 2023, trading 50,000 units of DDD stock currently worth $265,000.

What does 3D Systems do?

3d systems provides the most advanced and comprehensive 3d digital design and fabrication solutions available today, including 3d printers, print materials and cloud-sourced custom parts. its powerful ecosystem transforms entire industries by empowering professionals and consumers everywhere to bring their ideas to life using its vast material selection, including plastics, metals, ceramics and edibles. 3ds’ leading personalized medicine capabilities save lives and include end-to-end simulation, training and planning, and printing of surgical instruments and devices for personalized surgery and patient specific medical and dental devices. its democratized 3d digital design, fabrication and inspection products provide seamless interoperability and incorporate the latest immersive computing technologies. 3ds’ products and services disrupt traditional methods, deliver improved results and empower its customers to manufacture the future now.

Complete history of Ms. Krishnan stock trades at Quicklogic Corp and 3D Systems

3D Systems executives and stock owners

3D Systems executives and other stock owners filed with the SEC include:

• Herbert Koeck,
  Executive Vice President, Global Go To Market
• Andrew Johnson,
  Executive Vice President, Chief Legal Officer and Secretary
• Dr. Jeffrey A. Graves,
  Pres, CEO & Director
• Reji Puthenveetil,
  Exec. VP of Industrial Solutions
• Charles Hull,
  Chief Technology Officer, Executive Vice President, Director
• Menno Ellis,
  Exec. VP of Healthcare Solutions
• Andrew Martin Johnson,
  Exec. VP, Chief Legal Officer & Sec.
• Charles McClure,
  Independent Chairman of the Board
• Thomas Erickson,
  Independent Director
• William Curran,
  Independent Director
• Kevin Moore,
  Independent Director
• John Tracy,
  Independent Director
• William Humes,
  Independent Director
• Jeffrey Wadsworth,
  Independent Director
• Jimmy Kever,
  Independent Director
• Malissia Clinton,
  Independent Director
• Anthony Grabenau,
  Principal Accounting Officer
• Sadie Stern,
  Executive Vice President - People and Culture
• Reji Puthenveetil,
  Executive Vice President - Industrial Solutions
• Radhika Krishnan,
  Executive Vice President - Software and Healthcare
• Menno Ellis,
  Executive Vice President - Healthcare Solutions
• Jagtar Narula,
  Chief Financial Officer, Executive Vice President
• Jeffrey Graves,
  President, Chief Executive Officer, Executive Director
• Phyllis B. Nordstrom,
  Exec. VP, Chief People & Culture Officer and Chief Compliance Officer
• John E. Nypaver Jr.,
  VP of Investor Relations & Treasurer
• Dr. Brent Stucker Ph.D.,
  Chief Scientist
• Michael S. Crimmins,
  Sr. VP & Chief Accounting Officer
• Dr. Charles W. Hull,
  Co-Founder, Exec. VP, CTO of Regenerative Medicine & Director
• Jeff Blank,
  Exec. VP of Engineering & Product Devel.
• Allen Latty,
  Sr. VP of People & Culture
• Anthony J. Grabenau,
  VP, Global Corp. Controller & Principal Accounting Officer
• Jagtar Narula,
  Exec. VP & CFO
• Jeffrey D Creech,
  EVP & CFO
• Jim D Kever,
  Director
• John N Mc Mullen,
  EVP & CFO
• Kevin Mcalea,
  Vice President
• G Walter Ii Loewenbaum,
  Director
• Karen E Welke,
  Director
• Mark William Wright,
  EVP & COO
• Vyomesh Joshi,
  President and CEO
• Cathy L Lewis,
  Vice President
• Riper Daniel S Van,
  Director
• Andrew William Banasick Wright,
  SVP, GC & Secretary
• Vasant Padmanabhan,
  Director
• Joseph R. Zuiker,
  EVP, Engineering & Operations
• Philip C. Schultz,
  EVP, Operations
• Theodore A Hull,
  EVP & CFO on 11-11-2014
• Abraham N Reichental,
  President and CEO
• Peter Diamandis,
  Director
• David Robert Styka,
  VP & Chief Accounting Officer
• Damon Joseph Gregoire,
  VP, Chief Financial Officer
• Robert M Jr Grace,
  VP, General Counsel & Secretar
• Todd Booth,
  EVP & Chief Financial Officer
• Michael S Crimmins,
  Former SVP and CAO
• Wayne C Pensky,
  Interim CFO
• Jeff Blank,
  EVP, Engineering and Prod Dev
• David K Leigh,
  EVP & CTO (Additive Mfg)
• Phyllis B Nordstrom,
  EVP & CHRO
• Claudia Drayton,
  Director
• Michael Lynn Turner,
  
• Harriss T Currie,
  President, Regenerative Med
• Margaret E Wicklund,
  Chief Accounting Officer